The market has been up for six straight days, marijuana stocks look good, overall, and while we don’t quite have a buy signal from our intermediate-term trend-following indicator, we are very close. Today we are averaging up in three stocks.
Read More
The broad market has advanced nicely since mid-day Monday when news that the Fed might lower interest rates sparked a wave of buying. Long-term, the future is bright. But short-term, the portfolio is happy holding a cash level of 23%, deferring new buying.
Read More
Investing in marijuana stocks is a smart idea. But you can't just invest in any marijuana stocks. Here's the right way to do it.
Read More
The market’s larger, longer-term trend remains up, and the odds are that the market will be higher later this year. But short-term, the market remains in a correction, and marijuana stocks, as a whole, are not fighting the trend.
Read More
Investing in up markets is easy. From the December low until recently, the strong market provided a huge tailwind that sent marijuana stocks soaring—and had our portfolio, at the peak, up 57.2% year-to-date.
Read More
Overall, cannabis/marijuana stocks still look fine, even though the stocks were generally soft yesterday, so I’m not doing a full update, but there has been action, both good and bad, in a few stocks worth mentioning.
Read More
Looking at the revenues of the 14 companies in our Marijuana Portfolio, the average growth rate in the latest quarter, relative to the previous year, was 409%. The median, for you statistical fans, was 255%. This is one fast-growing sector!
Read More
The broad stock market remains healthy, with all indexes at or near highs, with the exception of small-cap stocks, which are lagging. A rising tide lifts all boats.
Read More
Today’s update is brief, but it does include a couple of important observations about the behavior of cannabis stocks in recent weeks, as well as updates on all the portfolio stocks.
Read More
Eleven years ago, Sears stock was at all-time highs, a $23 billion company. Now the company is bankrupt, and the stock is almost at zero. What happened?!
Read More
Though I didn't receive them from on top of Mount Sinai, consider the following the Ten Growth Stock Commandments every growth investor should live by.
Read More
Three analysts have increased their EPS estimates for this energy firm.
Read More
This low-cost optical component maker beat analysts’ earnings by $0.04 last quarter and is forecast to grow 44.4% this year.
Read More
Alcohol never really goes out of style, and neither do alcohol stocks. Here are three that stand out from a crowded field.
Read More
Cabot Quarterly Market Report
Click here to view the first quarter 2017 Quarterly Market Report for Prime Pro members and listen to the April 11 Cabot Prime Quarterly Analyst Teleconference.
Cabot Weekly Review
In this week's video, Mike Cintolo discusses the market's very encouraging action in recent days, makes...
Read More
SNaC is the method chief analyst Paul Goodwin uses to choose stocks for the Cabot Emerging Markets Investor
Read More
The SNaC Diet to Get Your Portfolio in Shape
Has the Stock Market Bottomed?
A Stock for Today’s Challenging Market Conditions
---
The SNaC Diet to Get Your Portfolio in Shape
It's February in New England. (Well, it's February everywhere, but the month means something entirely different to in...
Read More
While there isn’t any substitute for the diet and exercise you promised yourself you’d do six weeks ago, there’s a stock diet that will allow you to make huge progress in your equity portfolio. It’s called the SNaC Diet, and it’s the best to...
Read More
I believe in expertise. I think people who have lots of knowledge and experience are likely to be more helpful to me in finding reliable information and solving problems.
Read More
Growth investing is like deep-sea fishing for tuna. You spend a lot of time and effort preparing, getting the right equipment, selecting your path, using the right bait and starting your trawling run.
Read More
